A more in-depth study of the molecular mechanisms of E2 signaling on GBM and its interaction with other signaling factors, such as TGF-β, in specific cellular contexts is necessary to understand the effects of several inducers in this tumor, which could provide new strategies in the treatment of GBM. The gene discussed is TGFB1; the disease is glioblastoma.